nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Topotecan—ovarian cancer	0.173	0.354	CbGbCtD
Clindamycin—CYP3A4—Vinorelbine—ovarian cancer	0.122	0.249	CbGbCtD
Clindamycin—CYP3A4—Paclitaxel—ovarian cancer	0.0854	0.175	CbGbCtD
Clindamycin—CYP3A4—Docetaxel—ovarian cancer	0.0618	0.127	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—ovarian cancer	0.046	0.0945	CbGbCtD
Clindamycin—Vaginal infection—Epirubicin—ovarian cancer	0.000988	0.00193	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00098	0.00191	CcSEcCtD
Clindamycin—Fatigue—Topotecan—ovarian cancer	0.000978	0.00191	CcSEcCtD
Clindamycin—Dyspepsia—Melphalan—ovarian cancer	0.000978	0.00191	CcSEcCtD
Clindamycin—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000971	0.00189	CcSEcCtD
Clindamycin—Pain—Topotecan—ovarian cancer	0.00097	0.00189	CcSEcCtD
Clindamycin—Constipation—Topotecan—ovarian cancer	0.00097	0.00189	CcSEcCtD
Clindamycin—Vaginal inflammation—Doxorubicin—ovarian cancer	0.000968	0.00189	CcSEcCtD
Clindamycin—Epistaxis—Paclitaxel—ovarian cancer	0.000966	0.00188	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000959	0.00187	CcSEcCtD
Clindamycin—Fatigue—Melphalan—ovarian cancer	0.000958	0.00187	CcSEcCtD
Clindamycin—Dermatitis contact—Doxorubicin—ovarian cancer	0.000957	0.00187	CcSEcCtD
Clindamycin—Oesophagitis—Epirubicin—ovarian cancer	0.000956	0.00187	CcSEcCtD
Clindamycin—Rash maculo-papular—Epirubicin—ovarian cancer	0.000951	0.00186	CcSEcCtD
Clindamycin—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000951	0.00185	CcSEcCtD
Clindamycin—Pain—Melphalan—ovarian cancer	0.00095	0.00185	CcSEcCtD
Clindamycin—Hypersensitivity—Chlorambucil—ovarian cancer	0.000939	0.00183	CcSEcCtD
Clindamycin—Colitis—Doxorubicin—ovarian cancer	0.00093	0.00181	CcSEcCtD
Clindamycin—Gastrointestinal pain—Topotecan—ovarian cancer	0.000928	0.00181	CcSEcCtD
Clindamycin—Candida infection—Doxorubicin—ovarian cancer	0.000924	0.0018	CcSEcCtD
Clindamycin—Skin exfoliation—Doxorubicin—ovarian cancer	0.000924	0.0018	CcSEcCtD
Clindamycin—Asthenia—Chlorambucil—ovarian cancer	0.000915	0.00178	CcSEcCtD
Clindamycin—Vaginal infection—Doxorubicin—ovarian cancer	0.000914	0.00178	CcSEcCtD
Clindamycin—Neutropenia—Docetaxel—ovarian cancer	0.00091	0.00178	CcSEcCtD
Clindamycin—Hypotension—Vinorelbine—ovarian cancer	0.000907	0.00177	CcSEcCtD
Clindamycin—Pruritus—Chlorambucil—ovarian cancer	0.000902	0.00176	CcSEcCtD
Clindamycin—Urticaria—Topotecan—ovarian cancer	0.000902	0.00176	CcSEcCtD
Clindamycin—Abdominal pain—Topotecan—ovarian cancer	0.000897	0.00175	CcSEcCtD
Clindamycin—Body temperature increased—Topotecan—ovarian cancer	0.000897	0.00175	CcSEcCtD
Clindamycin—Oesophagitis—Doxorubicin—ovarian cancer	0.000885	0.00173	CcSEcCtD
Clindamycin—Urticaria—Melphalan—ovarian cancer	0.000883	0.00172	CcSEcCtD
Clindamycin—Rash maculo-papular—Doxorubicin—ovarian cancer	0.00088	0.00172	CcSEcCtD
Clindamycin—Thrombophlebitis—Epirubicin—ovarian cancer	0.000877	0.00171	CcSEcCtD
Clindamycin—Diarrhoea—Chlorambucil—ovarian cancer	0.000872	0.0017	CcSEcCtD
Clindamycin—Erythema multiforme—Paclitaxel—ovarian cancer	0.000869	0.0017	CcSEcCtD
Clindamycin—Dyspnoea—Vinorelbine—ovarian cancer	0.000866	0.00169	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00086	0.00168	CcSEcCtD
Clindamycin—Flushing—Paclitaxel—ovarian cancer	0.000853	0.00166	CcSEcCtD
Clindamycin—Jaundice—Docetaxel—ovarian cancer	0.000846	0.00165	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000838	0.00164	CcSEcCtD
Clindamycin—Fatigue—Vinorelbine—ovarian cancer	0.000837	0.00163	CcSEcCtD
Clindamycin—Hypersensitivity—Topotecan—ovarian cancer	0.000836	0.00163	CcSEcCtD
Clindamycin—Pain—Vinorelbine—ovarian cancer	0.00083	0.00162	CcSEcCtD
Clindamycin—Constipation—Vinorelbine—ovarian cancer	0.00083	0.00162	CcSEcCtD
Clindamycin—Hypersensitivity—Melphalan—ovarian cancer	0.000819	0.0016	CcSEcCtD
Clindamycin—Epistaxis—Docetaxel—ovarian cancer	0.000819	0.0016	CcSEcCtD
Clindamycin—Asthenia—Topotecan—ovarian cancer	0.000814	0.00159	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000812	0.00158	CcSEcCtD
Clindamycin—Vomiting—Chlorambucil—ovarian cancer	0.000811	0.00158	CcSEcCtD
Clindamycin—Agranulocytosis—Docetaxel—ovarian cancer	0.00081	0.00158	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000805	0.00157	CcSEcCtD
Clindamycin—Pruritus—Topotecan—ovarian cancer	0.000803	0.00157	CcSEcCtD
Clindamycin—Erythema—Paclitaxel—ovarian cancer	0.0008	0.00156	CcSEcCtD
Clindamycin—Asthenia—Melphalan—ovarian cancer	0.000797	0.00156	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—ovarian cancer	0.000795	0.00155	CcSEcCtD
Clindamycin—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000794	0.00155	CcSEcCtD
Clindamycin—Flatulence—Paclitaxel—ovarian cancer	0.000788	0.00154	CcSEcCtD
Clindamycin—Pruritus—Melphalan—ovarian cancer	0.000786	0.00153	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.000785	0.00153	CcSEcCtD
Clindamycin—Dysgeusia—Paclitaxel—ovarian cancer	0.000784	0.00153	CcSEcCtD
Clindamycin—Diarrhoea—Topotecan—ovarian cancer	0.000777	0.00151	CcSEcCtD
Clindamycin—Back pain—Paclitaxel—ovarian cancer	0.000774	0.00151	CcSEcCtD
Clindamycin—Urticaria—Vinorelbine—ovarian cancer	0.000771	0.0015	CcSEcCtD
Clindamycin—Muscle spasms—Paclitaxel—ovarian cancer	0.000769	0.0015	CcSEcCtD
Clindamycin—Abdominal pain—Vinorelbine—ovarian cancer	0.000767	0.0015	CcSEcCtD
Clindamycin—Body temperature increased—Vinorelbine—ovarian cancer	0.000767	0.0015	CcSEcCtD
Clindamycin—Diarrhoea—Melphalan—ovarian cancer	0.00076	0.00148	CcSEcCtD
Clindamycin—Nausea—Chlorambucil—ovarian cancer	0.000757	0.00148	CcSEcCtD
Clindamycin—Dizziness—Topotecan—ovarian cancer	0.00075	0.00146	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000745	0.00145	CcSEcCtD
Clindamycin—Anaemia—Paclitaxel—ovarian cancer	0.00074	0.00144	CcSEcCtD
Clindamycin—Erythema multiforme—Docetaxel—ovarian cancer	0.000737	0.00144	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000735	0.00143	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000726	0.00142	CcSEcCtD
Clindamycin—Flushing—Docetaxel—ovarian cancer	0.000723	0.00141	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—ovarian cancer	0.000722	0.00141	CcSEcCtD
Clindamycin—Vomiting—Topotecan—ovarian cancer	0.000722	0.00141	CcSEcCtD
Clindamycin—Vertigo—Paclitaxel—ovarian cancer	0.000719	0.0014	CcSEcCtD
Clindamycin—Leukopenia—Paclitaxel—ovarian cancer	0.000716	0.0014	CcSEcCtD
Clindamycin—Rash—Topotecan—ovarian cancer	0.000716	0.0014	CcSEcCtD
Clindamycin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000715	0.0014	CcSEcCtD
Clindamycin—Dermatitis—Topotecan—ovarian cancer	0.000715	0.00139	CcSEcCtD
Clindamycin—Headache—Topotecan—ovarian cancer	0.000711	0.00139	CcSEcCtD
Clindamycin—Vomiting—Melphalan—ovarian cancer	0.000707	0.00138	CcSEcCtD
Clindamycin—Rash—Melphalan—ovarian cancer	0.000701	0.00137	CcSEcCtD
Clindamycin—Dermatitis—Melphalan—ovarian cancer	0.0007	0.00137	CcSEcCtD
Clindamycin—Asthenia—Vinorelbine—ovarian cancer	0.000697	0.00136	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—ovarian cancer	0.000696	0.00136	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—ovarian cancer	0.000694	0.00135	CcSEcCtD
Clindamycin—Hypertension—Paclitaxel—ovarian cancer	0.000691	0.00135	CcSEcCtD
Clindamycin—Pruritus—Vinorelbine—ovarian cancer	0.000687	0.00134	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000684	0.00133	CcSEcCtD
Clindamycin—Erythema—Docetaxel—ovarian cancer	0.000678	0.00132	CcSEcCtD
Clindamycin—Nausea—Topotecan—ovarian cancer	0.000674	0.00132	CcSEcCtD
Clindamycin—Discomfort—Paclitaxel—ovarian cancer	0.000673	0.00131	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—ovarian cancer	0.000668	0.0013	CcSEcCtD
Clindamycin—Diarrhoea—Vinorelbine—ovarian cancer	0.000664	0.0013	CcSEcCtD
Clindamycin—Dysgeusia—Docetaxel—ovarian cancer	0.000664	0.0013	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—ovarian cancer	0.000661	0.00129	CcSEcCtD
Clindamycin—Nausea—Melphalan—ovarian cancer	0.00066	0.00129	CcSEcCtD
Clindamycin—Back pain—Docetaxel—ovarian cancer	0.000656	0.00128	CcSEcCtD
Clindamycin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000653	0.00127	CcSEcCtD
Clindamycin—Muscle spasms—Docetaxel—ovarian cancer	0.000652	0.00127	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—ovarian cancer	0.00065	0.00127	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—ovarian cancer	0.000644	0.00126	CcSEcCtD
Clindamycin—Dizziness—Vinorelbine—ovarian cancer	0.000642	0.00125	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000642	0.00125	CcSEcCtD
Clindamycin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000639	0.00125	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000633	0.00123	CcSEcCtD
Clindamycin—Anaemia—Docetaxel—ovarian cancer	0.000627	0.00122	CcSEcCtD
Clindamycin—Vomiting—Vinorelbine—ovarian cancer	0.000617	0.0012	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—ovarian cancer	0.000614	0.0012	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—ovarian cancer	0.000614	0.0012	CcSEcCtD
Clindamycin—Rash—Vinorelbine—ovarian cancer	0.000612	0.00119	CcSEcCtD
Clindamycin—Dermatitis—Vinorelbine—ovarian cancer	0.000612	0.00119	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—ovarian cancer	0.000612	0.00119	CcSEcCtD
Clindamycin—Hypotension—Paclitaxel—ovarian cancer	0.00061	0.00119	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.00061	0.00119	CcSEcCtD
Clindamycin—Headache—Vinorelbine—ovarian cancer	0.000608	0.00119	CcSEcCtD
Clindamycin—Leukopenia—Docetaxel—ovarian cancer	0.000607	0.00118	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—ovarian cancer	0.000601	0.00117	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000599	0.00117	CcSEcCtD
Clindamycin—Hypertension—Docetaxel—ovarian cancer	0.000586	0.00114	CcSEcCtD
Clindamycin—Dyspnoea—Paclitaxel—ovarian cancer	0.000582	0.00114	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00058	0.00113	CcSEcCtD
Clindamycin—Nausea—Vinorelbine—ovarian cancer	0.000577	0.00113	CcSEcCtD
Clindamycin—Dyspepsia—Paclitaxel—ovarian cancer	0.000575	0.00112	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—ovarian cancer	0.000571	0.00111	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—ovarian cancer	0.000569	0.00111	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—ovarian cancer	0.000568	0.00111	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—ovarian cancer	0.000568	0.00111	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000565	0.0011	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000564	0.0011	CcSEcCtD
Clindamycin—Fatigue—Paclitaxel—ovarian cancer	0.000563	0.0011	CcSEcCtD
Clindamycin—Pain—Paclitaxel—ovarian cancer	0.000558	0.00109	CcSEcCtD
Clindamycin—Constipation—Paclitaxel—ovarian cancer	0.000558	0.00109	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000554	0.00108	CcSEcCtD
Clindamycin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000553	0.00108	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—ovarian cancer	0.000552	0.00108	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—ovarian cancer	0.000546	0.00107	CcSEcCtD
Clindamycin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000542	0.00106	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000537	0.00105	CcSEcCtD
Clindamycin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000534	0.00104	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—ovarian cancer	0.000528	0.00103	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000526	0.00103	CcSEcCtD
Clindamycin—Urticaria—Paclitaxel—ovarian cancer	0.000519	0.00101	CcSEcCtD
Clindamycin—Hypotension—Docetaxel—ovarian cancer	0.000517	0.00101	CcSEcCtD
Clindamycin—Abdominal pain—Paclitaxel—ovarian cancer	0.000516	0.00101	CcSEcCtD
Clindamycin—Body temperature increased—Paclitaxel—ovarian cancer	0.000516	0.00101	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—ovarian cancer	0.000511	0.000997	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000505	0.000986	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—ovarian cancer	0.000497	0.000969	CcSEcCtD
Clindamycin—Dyspnoea—Docetaxel—ovarian cancer	0.000493	0.000963	CcSEcCtD
Clindamycin—Flushing—Epirubicin—ovarian cancer	0.000488	0.000951	CcSEcCtD
Clindamycin—Dyspepsia—Docetaxel—ovarian cancer	0.000487	0.000951	CcSEcCtD
Clindamycin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000481	0.000939	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000478	0.000932	CcSEcCtD
Clindamycin—Fatigue—Docetaxel—ovarian cancer	0.000477	0.000931	CcSEcCtD
Clindamycin—Pain—Docetaxel—ovarian cancer	0.000473	0.000923	CcSEcCtD
Clindamycin—Constipation—Docetaxel—ovarian cancer	0.000473	0.000923	CcSEcCtD
Clindamycin—Asthenia—Paclitaxel—ovarian cancer	0.000469	0.000914	CcSEcCtD
Clindamycin—Pruritus—Paclitaxel—ovarian cancer	0.000462	0.000901	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—ovarian cancer	0.00046	0.000897	CcSEcCtD
Clindamycin—Erythema—Epirubicin—ovarian cancer	0.000457	0.000892	CcSEcCtD
Clindamycin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000453	0.000883	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—ovarian cancer	0.000451	0.00088	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—ovarian cancer	0.000451	0.000879	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—ovarian cancer	0.000448	0.000874	CcSEcCtD
Clindamycin—Diarrhoea—Paclitaxel—ovarian cancer	0.000447	0.000872	CcSEcCtD
Clindamycin—Back pain—Epirubicin—ovarian cancer	0.000442	0.000863	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—ovarian cancer	0.00044	0.000858	CcSEcCtD
Clindamycin—Body temperature increased—Docetaxel—ovarian cancer	0.000438	0.000854	CcSEcCtD
Clindamycin—Abdominal pain—Docetaxel—ovarian cancer	0.000438	0.000854	CcSEcCtD
Clindamycin—Dizziness—Paclitaxel—ovarian cancer	0.000432	0.000842	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—ovarian cancer	0.000423	0.000826	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—ovarian cancer	0.000423	0.000825	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—ovarian cancer	0.000417	0.000814	CcSEcCtD
Clindamycin—Vomiting—Paclitaxel—ovarian cancer	0.000415	0.00081	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—ovarian cancer	0.000414	0.000809	CcSEcCtD
Clindamycin—Rash—Paclitaxel—ovarian cancer	0.000412	0.000803	CcSEcCtD
Clindamycin—Dermatitis—Paclitaxel—ovarian cancer	0.000411	0.000803	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—ovarian cancer	0.000411	0.000802	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—ovarian cancer	0.000409	0.000799	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—ovarian cancer	0.000409	0.000799	CcSEcCtD
Clindamycin—Headache—Paclitaxel—ovarian cancer	0.000409	0.000798	CcSEcCtD
Clindamycin—Hypersensitivity—Docetaxel—ovarian cancer	0.000408	0.000796	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—ovarian cancer	0.000407	0.000794	CcSEcCtD
Clindamycin—Asthenia—Docetaxel—ovarian cancer	0.000397	0.000775	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—ovarian cancer	0.000395	0.00077	CcSEcCtD
Clindamycin—Pruritus—Docetaxel—ovarian cancer	0.000392	0.000764	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—ovarian cancer	0.000391	0.000763	CcSEcCtD
Clindamycin—Nausea—Paclitaxel—ovarian cancer	0.000388	0.000757	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—ovarian cancer	0.000385	0.000751	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—ovarian cancer	0.00038	0.000742	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—ovarian cancer	0.000379	0.000739	CcSEcCtD
Clindamycin—Diarrhoea—Docetaxel—ovarian cancer	0.000379	0.000739	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000373	0.000728	CcSEcCtD
Clindamycin—Dizziness—Docetaxel—ovarian cancer	0.000366	0.000714	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000366	0.000713	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—ovarian cancer	0.000365	0.000713	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—ovarian cancer	0.000356	0.000695	CcSEcCtD
Clindamycin—Vomiting—Docetaxel—ovarian cancer	0.000352	0.000687	CcSEcCtD
Clindamycin—Rash—Docetaxel—ovarian cancer	0.000349	0.000681	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—ovarian cancer	0.000349	0.000681	CcSEcCtD
Clindamycin—Dermatitis—Docetaxel—ovarian cancer	0.000349	0.00068	CcSEcCtD
Clindamycin—Headache—Docetaxel—ovarian cancer	0.000347	0.000676	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000345	0.000674	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000338	0.00066	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—ovarian cancer	0.000333	0.000649	CcSEcCtD
Clindamycin—Nausea—Docetaxel—ovarian cancer	0.000329	0.000641	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—ovarian cancer	0.000329	0.000641	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—ovarian cancer	0.000323	0.00063	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000322	0.000629	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—ovarian cancer	0.000322	0.000628	CcSEcCtD
Clindamycin—Constipation—Epirubicin—ovarian cancer	0.000319	0.000623	CcSEcCtD
Clindamycin—Pain—Epirubicin—ovarian cancer	0.000319	0.000623	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—ovarian cancer	0.000308	0.000601	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000305	0.000596	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—ovarian cancer	0.000304	0.000593	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000298	0.000582	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—ovarian cancer	0.000298	0.000581	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—ovarian cancer	0.000297	0.000579	CcSEcCtD
Clindamycin—Pain—Doxorubicin—ovarian cancer	0.000295	0.000576	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—ovarian cancer	0.000295	0.000576	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—ovarian cancer	0.000295	0.000576	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—ovarian cancer	0.000295	0.000576	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000282	0.000551	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—ovarian cancer	0.000275	0.000537	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—ovarian cancer	0.000274	0.000535	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—ovarian cancer	0.000273	0.000533	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—ovarian cancer	0.000273	0.000533	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—ovarian cancer	0.000268	0.000523	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—ovarian cancer	0.000264	0.000515	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—ovarian cancer	0.000255	0.000498	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000254	0.000497	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—ovarian cancer	0.000248	0.000484	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—ovarian cancer	0.000247	0.000482	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—ovarian cancer	0.000244	0.000477	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—ovarian cancer	0.000237	0.000463	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—ovarian cancer	0.000236	0.000461	CcSEcCtD
Clindamycin—Rash—Epirubicin—ovarian cancer	0.000235	0.000459	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—ovarian cancer	0.000235	0.000459	CcSEcCtD
Clindamycin—Headache—Epirubicin—ovarian cancer	0.000234	0.000456	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—ovarian cancer	0.000228	0.000446	CcSEcCtD
Clindamycin—Nausea—Epirubicin—ovarian cancer	0.000222	0.000433	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—ovarian cancer	0.00022	0.000428	CcSEcCtD
Clindamycin—Rash—Doxorubicin—ovarian cancer	0.000218	0.000425	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—ovarian cancer	0.000218	0.000425	CcSEcCtD
Clindamycin—Headache—Doxorubicin—ovarian cancer	0.000216	0.000422	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—ovarian cancer	0.000205	0.0004	CcSEcCtD
